Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjögren’s syndrome

1 Markovic SN Inwards DJ Frigas EA Phyliky RP . Acquired C1 esterase inhibitor deficiency. Ann Intern Med 2000; 132: 144 – 150 .

2 Zingale LC Castelli R Zanichelli A Cicardi M . Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunol Allergy Clin North Am 2006; 26: 669 – 690 .

3 Ziakas PD Giannouli S Psimenou E Evangelia K Tzioufas AG Voulgarelis M . Acquired angioedema: a new target for rituximab? Haematologica 2004; 89: ELT13 .

4 Levi M Hack CE van Oers MH . Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency. Am J Med 2006; 119: e3 – 5 .

5 Sneller MC . Rituximab and Wegener's granulomatosis: are B cells a target in vasculitis treatment? Arthritis Rheum 2005; 52: 1 – 5 .